Improved 5-Factor Prognostic Classification of Patients Receiving Salvage Systemic Therapy for Advanced Urothelial Carcinoma Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Transitional Cell
  • Serum Albumin
  • Urinary Bladder Neoplasms

abstract

  • Albumin was externally validated as a prognostic factor for overall survival after accounting for time from prior chemotherapy, hemoglobin, performance status and liver metastasis status in patients receiving salvage systemic therapy for advanced urothelial carcinoma. The discovery of molecular prognostic factors is a priority to further enhance this new preferred 5-factor clinical prognostic model.

publication date

  • February 2016

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5025874

Digital Object Identifier (DOI)

  • 10.1016/j.juro.2015.07.111

PubMed ID

  • 26292040

Additional Document Info

start page

  • 277

end page

  • 82

volume

  • 195

number

  • 2